231 related articles for article (PubMed ID: 26202613)
1. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.
Gerak LR; Zanettini C; Koek W; France CP
Psychopharmacology (Berl); 2015 Oct; 232(19):3637-47. PubMed ID: 26202613
[TBL] [Abstract][Full Text] [Related]
2. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
Gerak LR; France CP
J Pharmacol Exp Ther; 2016 May; 357(2):357-66. PubMed ID: 26937020
[TBL] [Abstract][Full Text] [Related]
3. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
Maguire DR; Yang W; France CP
J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317
[TBL] [Abstract][Full Text] [Related]
4. Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.
Maguire DR; France CP
J Pharmacol Exp Ther; 2014 Nov; 351(2):383-9. PubMed ID: 25194020
[TBL] [Abstract][Full Text] [Related]
5. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
Ulugol A; Topuz RD; Gunduz O; Kizilay G; Karadag HC
Fundam Clin Pharmacol; 2016 Dec; 30(6):537-548. PubMed ID: 27371029
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates.
Ding H; Kiguchi N; Mabry KM; Kishioka S; Ko MC
Neuropharmacology; 2023 Feb; 223():109328. PubMed ID: 36356937
[TBL] [Abstract][Full Text] [Related]
8. Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys.
Weed PF; Gerak LR; France CP
Eur J Pharmacol; 2018 Aug; 833():94-99. PubMed ID: 29807027
[TBL] [Abstract][Full Text] [Related]
9. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
Vivian JA; Kishioka S; Butelman ER; Broadbear J; Lee KO; Woods JH
J Pharmacol Exp Ther; 1998 Aug; 286(2):697-703. PubMed ID: 9694923
[TBL] [Abstract][Full Text] [Related]
10. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids.
Erwin LL; Nilges MR; Denys IB; Sutphen JC; Friend AJ; Kapusta DR; Winsauer PJ
Pharmacol Biochem Behav; 2021 Aug; 207():173218. PubMed ID: 34118232
[TBL] [Abstract][Full Text] [Related]
11. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
12. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
McMahon LR
Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
[TBL] [Abstract][Full Text] [Related]
13. Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure.
Maguire DR; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2357-2365. PubMed ID: 29860612
[TBL] [Abstract][Full Text] [Related]
14. Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
Li JX; McMahon LR; Gerak LR; Becker GL; France CP
Psychopharmacology (Berl); 2008 Aug; 199(2):199-208. PubMed ID: 18470505
[TBL] [Abstract][Full Text] [Related]
15. Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice.
Yeşilyurt O; Dogrul A
Neurosci Lett; 2004 Nov; 371(2-3):122-7. PubMed ID: 15519741
[TBL] [Abstract][Full Text] [Related]
16. The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.
Wilson-Poe AR; Pocius E; Herschbach M; Morgan MM
Pharmacol Biochem Behav; 2013 Jan; 103(3):444-9. PubMed ID: 23063785
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid/cannabinoid mixtures on impulsivity and memory in rhesus monkeys.
Minervini V; France CP
Behav Pharmacol; 2020 Apr; 31(2&3):233-248. PubMed ID: 32101988
[TBL] [Abstract][Full Text] [Related]
18. Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexus.
Basilico L; Parolaro D; Colleoni M; Costa B; Giagnoni G
Eur J Pharmacol; 1999 Jul; 376(3):265-71. PubMed ID: 10448886
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of tolerance in the guinea pig ileum produced by chronic in vivo exposure to opioid versus cannabinoid agonists.
Maguma H; Thayne K; Taylor DA
Biochem Pharmacol; 2010 Aug; 80(4):522-32. PubMed ID: 20478271
[TBL] [Abstract][Full Text] [Related]
20. Topical cannabinoid enhances topical morphine antinociception.
Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
